TNNT2 and congestive heart failure: The EMPEROR-Preserved study, conducted on 5988 patients, developed a prognostic model for CHF patients with a preserved ejection fraction (HFpEF), focusing on biomarkers such as NT-proBNP and high-sensitivity cardiac troponin T (hs-cTnT).